AMAmirthasingam Manoraj

Amirthasingam Manoraj

*This is an algorithmically generated author record based on publicly available information.

Amirthasingam Manoraj has a total of 17 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Comparative Extraction, Preliminary Phytochemical Screening, and Antioxidant Activity of Mirabilis jalapa L. Tuberous Roots Found in Sri Lanka

    by Ladhurshika Nadarajah, Luvedika Maheshwaran, Nimesha Senadeera, Thamara Navarathna, Manoraj Amirthasingam, Anchala I. Kuruppu, Ambalanduwe K. Chandana, Ranjith N. Pathirana, Chathuranga B. Ranaweera

    Mirabilis jalapa, or the Four O’clock plant, is an ornamental plant that has medicinal value due to its various phytochemical compositions. This study aims to examine the M. jalapa roots for their phytochemical spectrum and determine their in vitro antioxidant capacity. The plant was collected and authenticated, and then maceration, sonication, and Soxhlet extraction techniques were employed for aqueous, methanol, dichloromethane (DCM), and hexane extracts. Thin-layer chromatography (TLC) coupled with spray reagents was used to screen bioactives. Total Phenolic Content (TPC), DPPH (2,2-diphenyl-1-picrylhydrazyl), and ABTS (2,2′-azino-bis (3-ethylbenzothiazoline-6-sulfonic acid)) radical-scavenging activity assays were performed to investigate the antioxidant potential. TLC screening revealed that maceration and Soxhlet extraction separated most compounds. The TPC values of methanol and aqueous macerates were the highest among all extracts. In the DPPH scavenging assay, these extracts showed a significantly higher activity, with IC50 values (half-maximal inhibitory concentration) below the lowest concentration tested (<0.03125 mg/mL). The ABTS assay identified the same two extracts as the most active, but scavenging remained below 50% (maximum 43.30% at 1 mg/mL); therefore, IC50 could not be determined. Overall, methanol and aqueous extracts of M. jalapa roots showed significantly higher antioxidant activity, perhaps due to their variety of bioactive compounds that justified their incorporation in traditional medicine.

  • Open Access

    Diagnosis of Neerizhivu Mathumeham (Diabetes Mellitus Type 2) using the Siddha and modern diagnostic methods - A cross-sectional observational study

    by Kalaimony Rabindrakumar Vidya Dharshini, Muthusamy Krishnaveni, Amirthasingam Manoraj

    Siddha Medicine, is an oldest traditional medical system, describes Neerizhivu Madhumeham (NM), is often compared with diabetes mellitus (DM). The Siddha system of medicine incorporates a unique set of diagnostic procedures. Modern medical practices have utilized biomedical knowledge to diagnose diseases. Yet comparative diagnostic analysis between both systems remains limited. The purpose of the study is to examine the connection between Siddha and modern diagnostic approaches for NM. A cross-sectional observational study was conducted at Government Siddha Medical College, Palayamkottai (GSMCP), Government District Headquarters Hospital, Thoothukudi, and Gopalasamudram village, India. Sixty patients diagnosed with DM, aged 18-64 years, were randomly selected based on selection criteria. Written informed consent was acquired from each participant, and the study received ethical approval from the GSMCP Ethics Committee. Patients underwent diagnostic assessments using Siddha (neerkuri, neikuri, nadi, and manikkadai), and modern (urine full report and fasting plasma glucose (FPG)) diagnostic techniques. Data analysis was employed using standard statistical methods. The findings revealed that the Seerana pakkuva neer type of urine was associated with low FPG (199.6±15.4 mg/dL). Lower FPG was observed in patients with Vathapiththam and Piththavatham. A significant correlation was detected between neikuri (P=0.02), nadi (P=0.015), with FPG. A movement ‘Pendulum’ of nadi was noted in all DM patient. Elevated manikkadai nool values may serve as an indicator of poor glycaemic control. The study suggests that neikuri and nadi could be serve as a diagnostic tool for DM. However, further comprehensive studies are necessary prior to clinical practice.

  • Open Access

    Synergistic activity between Triphala and selected antibiotics against drug resistant clinical isolates

    by Amirthasingam Manoraj, Vasanthi Thevanesam, B. M. R. Bandara, Asela Ekanayake, Veranja Liyanapathirana

    Triphala is an indigenous medical product used for a variety of diseases. This study was conducted to determine the effect of Triphala on antibiotic properties of gentamicin and oxacillin against multi-drug resistant organisms. The checkerboard method was used to determine the synergy of Triphala with gentamicin and oxacillin against multi-drug resistant (MDR) Gram negative bacilli and methicillin-resistant Staphylococcus aureus (MRSA) using 2,3,5-triphenyltetrazolium chloride (TTC) assay. Fractional inhibitory concentration (FIC) index was calculated. When tested alone, the minimum inhibitory concentration (MIC) values of gentamicin for Gram negative isolates ranged from 8 to > 64 μg/ml. The MIC values of gentamicin for the Gram negative isolates ranged from 1 to 32 μg/ml when tested with Triphala. The FIC index was < 1 indicating a synergistic interaction in 10 of the 11 isolates and it was 1 indicating an additive effect in one isolate. The MIC values of oxacillin for MRSA isolates ranged from 4 to > 16 μg/ml with all MICs being equal to or higher than the resistance cut-off level. The MIC level with the addition of Triphala ranged from 0.25 to 4 μg/ml. FIC index was < 1 for all tested isolates indicating a synergistic interaction. Triphala has synergistic activity with gentamicin against the selected MDR Gram negative bacilli and with oxacillin against MRSA isolates warranting further studies on the possibility of clinical use.


  • Open Access

    Terminalia bellirica fruit extracts: in-vitro antibacterial activity against selected multidrug-resistant bacteria, radical scavenging activity and cytotoxicity study on BHK-21 cells

    by M. Priyanga Jayamal Dharmaratne, Amirthasingam Manoraj, Vasanthi Thevanesam, Asela Ekanayake, Nimal Savitri Kumar, Veranja Liyanapathirana, Eranga Abeyratne, B. M. Ratnayake Bandara

    Identification of novel sources for developing new antibiotics is imperative with the emergence of antibiotic resistant bacteria. The fruits of Terminalia bellirica (Gaertn) Roxb., widely used in traditional medicine, were evaluated for antibacterial activity against multidrug-resistant (MDR) bacteria, antioxidant activity and cytotoxicity. Twelve solvent extracts of T. bellirica fruits were prepared by direct aqueous extraction and sequential extraction with dichloromethane, methanol and water using Soxhlet, bottle-shaker and ultrasound sonicator methods. Antibacterial activity of the extracts was tested against 16 strains MDR bacteria—methicillin-resistant Staphylococcus aureus (MRSA), extended spectrum β-lactamase (ESBL) producing Escherichia coli and MDR Acinetobacter spp., Klebsiella pneumoniae and Pseudomonas aeruginosa—and 4 control organisms, using the cut-well diffusion method. The minimum inhibitory concentration (MIC) was determined using an agar dilution method. The radical scavenging activity of six antibacterial extracts was screened against 2,2′-diphenyl-2-picrylhydrazyl (DPPH) and correlation was established between EC50 (50% effective concentration) values and the total phenolic content (TPC). Cytotoxicity was determined for the most potent antibacterial extract on baby hamster kidney (BHK-21) cells by Tryphan Blue exclusion method. Statistical analysis was carried out by one-way analysis of variance at significant level p < 0.05 using “SigmaPlot 10” and “R 3.2.0” software. All aqueous and methanol extracts displayed antibacterial activity (MIC 0.25–4 mg/mL) against all strains of MRSA, MDR Acinetobacter spp. and MDR P. aeruginosa. The sequential aqueous extracts (MIC, 4 mg/mL) inhibited ESBL producing-E. coli. None of the extracts exhibited activity against MDR K. pneumoniae (MIC > 5 mg/mL). The sequential methanol extract (Soxhlet) recorded high antibacterial activity and the highest DPPH radical scavenging activity (EC50, 6.99 ± 0.15 ppm) and TPC content (188.71 ± 2.12 GAE mg/g). The IC50 (50% inhibition concentration) values of the most potent antibacterial extract—the direct aqueous extract from reflux method—on BHK-21 cells were 2.62 ± 0.06 and 1.45 ± 0.08 mg/ml with 24 and 48 h exposure, respectively. Results indicate that T. bellirica fruit is a potential source for developing broad-spectrum antibacterial drugs against MDR bacteria, which are non-toxic to mammalian cells and impart health benefits by high antioxidant activity.